Molbio Diagnostics to expand Truenat to 52 diseases, plans wider US presence
The company also owns a stake in OptraScan, a digital pathology company that uses AI to identify which biopsy slides a pathologist should focus on ...
Read the original at CNBC TV18 ↗
- Topics
- Healthcare
- Tracked via
- “that uses AI to”